Cargando…

Corrigendum: Network pharmacology integrated with experimental validation to explore the therapeutic role and potential mechanism of Epimedium for spinal cord injury

Detalles Bibliográficos
Autores principales: Fu, Xuanhao, Ma, Boyuan, Zhou, Mengmeng, Cheng, Yuelin, Liu, Linyan, Kan, Shunli, Liu, Chengjiang, Zhao, Xinyan, Feng, Sa, Zhu, Haoqiang, Hu, Wei, Jiang, Zehua, Zhu, Rusen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411349/
https://www.ncbi.nlm.nih.gov/pubmed/37564784
http://dx.doi.org/10.3389/fnmol.2023.1257836
_version_ 1785086646082863104
author Fu, Xuanhao
Ma, Boyuan
Zhou, Mengmeng
Cheng, Yuelin
Liu, Linyan
Kan, Shunli
Liu, Chengjiang
Zhao, Xinyan
Feng, Sa
Zhu, Haoqiang
Hu, Wei
Jiang, Zehua
Zhu, Rusen
author_facet Fu, Xuanhao
Ma, Boyuan
Zhou, Mengmeng
Cheng, Yuelin
Liu, Linyan
Kan, Shunli
Liu, Chengjiang
Zhao, Xinyan
Feng, Sa
Zhu, Haoqiang
Hu, Wei
Jiang, Zehua
Zhu, Rusen
author_sort Fu, Xuanhao
collection PubMed
description
format Online
Article
Text
id pubmed-10411349
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-104113492023-08-10 Corrigendum: Network pharmacology integrated with experimental validation to explore the therapeutic role and potential mechanism of Epimedium for spinal cord injury Fu, Xuanhao Ma, Boyuan Zhou, Mengmeng Cheng, Yuelin Liu, Linyan Kan, Shunli Liu, Chengjiang Zhao, Xinyan Feng, Sa Zhu, Haoqiang Hu, Wei Jiang, Zehua Zhu, Rusen Front Mol Neurosci Molecular Neuroscience Frontiers Media S.A. 2023-07-26 /pmc/articles/PMC10411349/ /pubmed/37564784 http://dx.doi.org/10.3389/fnmol.2023.1257836 Text en Copyright © 2023 Fu, Ma, Zhou, Cheng, Liu, Kan, Liu, Zhao, Feng, Zhu, Hu, Jiang and Zhu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Molecular Neuroscience
Fu, Xuanhao
Ma, Boyuan
Zhou, Mengmeng
Cheng, Yuelin
Liu, Linyan
Kan, Shunli
Liu, Chengjiang
Zhao, Xinyan
Feng, Sa
Zhu, Haoqiang
Hu, Wei
Jiang, Zehua
Zhu, Rusen
Corrigendum: Network pharmacology integrated with experimental validation to explore the therapeutic role and potential mechanism of Epimedium for spinal cord injury
title Corrigendum: Network pharmacology integrated with experimental validation to explore the therapeutic role and potential mechanism of Epimedium for spinal cord injury
title_full Corrigendum: Network pharmacology integrated with experimental validation to explore the therapeutic role and potential mechanism of Epimedium for spinal cord injury
title_fullStr Corrigendum: Network pharmacology integrated with experimental validation to explore the therapeutic role and potential mechanism of Epimedium for spinal cord injury
title_full_unstemmed Corrigendum: Network pharmacology integrated with experimental validation to explore the therapeutic role and potential mechanism of Epimedium for spinal cord injury
title_short Corrigendum: Network pharmacology integrated with experimental validation to explore the therapeutic role and potential mechanism of Epimedium for spinal cord injury
title_sort corrigendum: network pharmacology integrated with experimental validation to explore the therapeutic role and potential mechanism of epimedium for spinal cord injury
topic Molecular Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411349/
https://www.ncbi.nlm.nih.gov/pubmed/37564784
http://dx.doi.org/10.3389/fnmol.2023.1257836
work_keys_str_mv AT fuxuanhao corrigendumnetworkpharmacologyintegratedwithexperimentalvalidationtoexplorethetherapeuticroleandpotentialmechanismofepimediumforspinalcordinjury
AT maboyuan corrigendumnetworkpharmacologyintegratedwithexperimentalvalidationtoexplorethetherapeuticroleandpotentialmechanismofepimediumforspinalcordinjury
AT zhoumengmeng corrigendumnetworkpharmacologyintegratedwithexperimentalvalidationtoexplorethetherapeuticroleandpotentialmechanismofepimediumforspinalcordinjury
AT chengyuelin corrigendumnetworkpharmacologyintegratedwithexperimentalvalidationtoexplorethetherapeuticroleandpotentialmechanismofepimediumforspinalcordinjury
AT liulinyan corrigendumnetworkpharmacologyintegratedwithexperimentalvalidationtoexplorethetherapeuticroleandpotentialmechanismofepimediumforspinalcordinjury
AT kanshunli corrigendumnetworkpharmacologyintegratedwithexperimentalvalidationtoexplorethetherapeuticroleandpotentialmechanismofepimediumforspinalcordinjury
AT liuchengjiang corrigendumnetworkpharmacologyintegratedwithexperimentalvalidationtoexplorethetherapeuticroleandpotentialmechanismofepimediumforspinalcordinjury
AT zhaoxinyan corrigendumnetworkpharmacologyintegratedwithexperimentalvalidationtoexplorethetherapeuticroleandpotentialmechanismofepimediumforspinalcordinjury
AT fengsa corrigendumnetworkpharmacologyintegratedwithexperimentalvalidationtoexplorethetherapeuticroleandpotentialmechanismofepimediumforspinalcordinjury
AT zhuhaoqiang corrigendumnetworkpharmacologyintegratedwithexperimentalvalidationtoexplorethetherapeuticroleandpotentialmechanismofepimediumforspinalcordinjury
AT huwei corrigendumnetworkpharmacologyintegratedwithexperimentalvalidationtoexplorethetherapeuticroleandpotentialmechanismofepimediumforspinalcordinjury
AT jiangzehua corrigendumnetworkpharmacologyintegratedwithexperimentalvalidationtoexplorethetherapeuticroleandpotentialmechanismofepimediumforspinalcordinjury
AT zhurusen corrigendumnetworkpharmacologyintegratedwithexperimentalvalidationtoexplorethetherapeuticroleandpotentialmechanismofepimediumforspinalcordinjury